[1] |
González-Moles MA, Warnakulasuriya S, González-Ruiz I,et al. Worldwide prevalence of oral lichen planus:A systematic review and meta-analysis[J]. Oral Dis, 2021, 27(4):813-828. DOI: 10.1111/odi.13323.
|
[2] |
|
[3] |
Gururaj N, Hasinidevi P, Janani V,et al. Diagnosis and management of oral lichen planus - Review[J]. J Oral Maxillofac Pathol, 2021, 25(3):383-393. DOI: 10.4103/jomfp.jomfp_386_21.
|
[4] |
王倩,徐偲,程喆,等. 490例口腔扁平苔藓伴发全身疾病的相关分析[C]//2018年中华口腔医学会第十次全国口腔黏膜病学术大会暨第八次全国口腔中西医结合学术大会论文集,上海,2018:39-41.
|
[5] |
Hasan S, Ahmed S, Kiran R,et al. Oral lichen planus and associated comorbidities:An approach to holistic health[J]. J Family Med Prim Care, 2019, 8(11):3504-3517. DOI: 10.4103/jfmpc.jfmpc_749_19.
|
[6] |
潘蕾,唐国瑶.口腔扁平苔藓患者心血管疾病风险研究[C]//2018年中华口腔医学会第十次全国口腔黏膜病学术大会暨第八次全国口腔中西医结合学术大会论文集,上海,2018:175-177.
|
[7] |
Ying J, Xiang W, Qiu Y,et al. Risk of metabolic syndrome in patients with lichen planus:A systematic review and meta-analysis[J]. PLoS One, 2020, 15(8):e238005. DOI: 10.1371/journal.pone.0238005.
|
[8] |
Radic T, Cigic L, Glavina A,et al. Lipid profiles and cardiovascular risk in patients with oral lichen planus[J]. Dent J (Basel), 2022, 10(4):61. DOI: 10.3390/dj10040061.
|
[9] |
Conrotto D, Barattero R, Carbone M,et al. Can atrophic-erosive oral lichen planus promote cardiovascular diseases?A population-based study[J]. Oral Dis, 2018, 24(1-2):215-218. DOI: 10.1111/odi.12700.
|
[10] |
Grover C, Kharghora G, Baran R. Nail lichen planus:A review of clinical presentation,diagnosis and therapy[J]. Ann Dermatol Venereol, 2022, 149(3):150-164. DOI: 10.1016/j.annder.2022.01.010.
|
[11] |
Balakumar P, Kavitha M, Nanditha S. Cardiovascular drugs-induced oral toxicities:A murky area to be revisited and illuminated[J]. Pharmacol Res, 2015, 102:81-89. DOI: 10.1016/j.phrs.2015.09.007.
|
[12] |
|
[13] |
Aravind T, Jnardhanan M, Suresh R,et al. Histopathologic evaluation of oral lichen planus and oral lichenoid reaction:A comparative analysis based on basement membrane thickness and the distribution of mast cells[J]. J Oral Maxillofac Pathol, 2021, 25(3):549-550. DOI: 10.4103/jomfp.JOMFP_220_20.
|
[14] |
Hua F. New insights into diabetes mellitus and its complications:A narrative review[J]. Ann Transl Med, 2020, 8(24):1689. DOI: 10.21037/atm-20-7243.
|
[15] |
Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications[J]. Nat Rev Nephrol, 2020, 16(7):377-390. DOI: 10.1038/s41581-020-0278-5.
|
[16] |
American Diabetes Association. 2. Classification and diagnosis of diabetes:Standards of medical care in diabetes-2021[J]. Diabetes Care, 2021, 44(Suppl 1):S15-S33. DOI: 10.2337/dc21-S002.
|
[17] |
González-Moles MÁ, Ramos-García P. State of evidence on oral health problems in diabetic patients:A critical review of the literature[J]. J Clin Med, 2021, 10(22):5383. DOI: 10.3390/jcm10225383.
|
[18] |
Otero Rey EM, Yáñez-Busto A, Rosa Henriques IF,et al. Lichen planus and diabetes mellitus:Systematic review and meta-analysis[J]. Oral Dis, 2019, 25(5):1253-1264. DOI: 10.1111/odi.12977.
|
[19] |
Mallah N, Ignacio Varela-Centelles P, Seoane-Romero J,et al. Diabetes mellitus and oral lichen planus:A systematic review and meta-analysis[J]. Oral Dis, 2021. DOI: 10.1111/odi.13927.
|
[20] |
Mauri-Obradors E, Estrugo-Devesa A, Jané-Salas E,et al. Oral manifestations of diabetes mellitus. A systematic review[J]. Med Oral Patol Oral Cir Bucal, 2017, 22(5):e586-e594. DOI: 10.4317/medoral.21655.
|
[21] |
de Porras-Carrique T, Ramos-García P, Aguilar-Diosdado M,et al. Autoimmune disorders in oral lichen planus:A systematic review and meta-analysis[J]. Oral Dis, 2022. DOI: 10.1111/odi.14127.
|
[22] |
Dave A, Shariff J, Philipone E. Association between oral lichen planus and systemic conditions and medications:Case-control study[J]. Oral Dis, 2021, 27(3):515-524. DOI: 10.1111/odi.13572.
|
[23] |
Zhao W, Yang Y, Wu F,et al. The reciprocal association between diabetes mellitus and erosive oral lichen planus[J]. Oral Dis, 2019, 25(4):1235-1236. DOI: 10.1111/odi.13050.
|
[24] |
Li D, Li J, Li C,et al. The association of thyroid disease and oral lichen planus:A literature review and meta-analysis[J]. Front Endocrinol(Lausanne), 2017, 8:310. DOI: 10.3389/fendo.2017.00310.
|
[25] |
Tang Y, Shi L, Jiang B,et al. A cross-sectional study of oral lichen planus associated with thyroid diseases in east china[J]. Front Endocrinol(Lausanne), 2019, 10:928. DOI: 10.3389/fendo.2019.00928.
|
[26] |
Hirota S, Marui S, Migliari D. Does autoimmune thyroid disorder act as a predisposing factor in the development of oral lichen planus?[J]. Oral Dis, 2020. DOI: 10.1111/odi.13339.
|
[27] |
Amato-Cuartas PA,Tabares-Quintero AE,Vélez-Jaramillo LF,et al. Coexistence of thyroid disease and oral lichen planus in a Colombian population[J]. Acta Odontol Latinoam,2019,32(2):71-74.
|
[28] |
Wu P, Luo S, Zhou T,et al. Possible mechanisms involved in the cooccurrence of oral lichen planus and Hashimoto′s thyroiditis[J]. Mediators Inflamm, 2020, 2020:6309238. DOI: 10.1155/2020/6309238.
|
[29] |
Robledo-Sierra J, Landin-Wilhelmsen K, Filipsson NH,et al. A mechanistic linkage between oral lichen planus and autoimmune thyroid disease[J]. Oral Dis, 2018, 24(6):1001-1011. DOI: 10.1111/odi.12850.
|
[30] |
|
[31] |
|
[32] |
Arduino PG, Karimi D, Tirone F,et al. Evidence of earlier thyroid dysfunction in newly diagnosed oral lichen planus patients:A hint for endocrinologists[J]. Endocr Connect, 2017, 6(8):726-730. DOI: 10.1530/EC-17-0262.
|
[33] |
Scelza G, Amato A, Pagano AM,et al. Effect of hepatitis C antiviral therapy on oral lichen planus and hyposalivation in inmates[J]. Ann Gastroenterol, 2022, 35(1):74-79. DOI: 10.20524/aog.2021.0672.
|
[34] |
汪苑苑,王嘉祺,关晓兵.口腔扁平苔藓感染相关因素的研究进展[J].北京口腔医学,2019,27(4):232-235.
|
[35] |
Cozzani E, Herzum A, Burlando M,et al. Cutaneous manifestations of HAV,HBV,HCV[J]. Ital J Dermatol Venerol, 2021, 156(1):5-12. DOI: 10.23736/S2784-8671.19.06488-5.
|
[36] |
Villa TG, Sánchez-Pérez A, Sieiro C. Oral lichen planus:A microbiologist point of view[J]. Int Microbiol, 2021, 24(3):275-289. DOI: 10.1007/s10123-021-00168-y.
|
[37] |
di Stasio D, Lucchese A, Romano A,et al. The clinical impact of direct-acting antiviral treatment on patients affected by hepatitis C virus-related oral lichen planus:A cohort study[J]. Clin Oral Investig, 2022, 26(8):5409-5417. DOI: 10.1007/s00784-022-04507-9.
|
[38] |
|
[39] |
Mokni M, Rybojad M, Puppin D,et al. Lichen planus and hepatitis C virus[J]. J Am Acad Dermatol, 1991, 24(5 Pt 1):792. DOI: 10.1016/s0190-9622(08)80376-3.
|
[40] |
Nosratzehi T. Oral lichen planus:An overview of potential risk factors,biomarkers and treatments[J]. Asian Pac J Cancer Prev, 2018, 19(5):1161-1167. DOI: 10.22034/APJCP.2018.19.5.1161.
|
[41] |
Offen E, Allison JR. What is the malignant transformation potential of oral lichen planus?[J]. Evid Based Dent, 2022, 23(1):36-37. DOI: 10.1038/s41432-022-0240-4.
|
[42] |
周瑜,王智,曾昕,等.口腔扁平苔藓198例横断面研究[C]//第七届全国口腔黏膜病暨第五届口腔中西医结合大会论文汇编,北京,2008.
|
[43] |
Tao JH, Cheng M, Tang JP,et al. Foxp3,regulatory T cell,and autoimmune diseases[J]. Inflammation, 2017, 40(1):328-339. DOI: 10.1007/s10753-016-0470-8.
|
[44] |
Rios DA, Casciato PC, Caldirola MS,et al. Chronic hepatitis C pathogenesis:Immune response in the liver microenvironment and peripheral compartment[J]. Front Cell Infect Microbiol, 2021, 11:712105. DOI: 10.3389/fcimb.2021.712105.
|
[45] |
Pilli M, Penna A, Zerbini A,et al. Oral lichen planus pathogenesis:A role for the HCV-specific cellular immune response[J]. Hepatology, 2002, 36(6):1446-1452. DOI: 10.1053/jhep.2002.37199.
|
[46] |
Georgescu SR, Tampa M, Mitran MI,et al. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection[J]. Exp Ther Med, 2019, 17(2):1045-1051. DOI: 10.3892/etm.2018.6987.
|
[47] |
Nagao Y, Tsuji M. Effects of hepatitis C virus elimination by direct-acting antiviral agents on the occurrence of oral lichen planus and periodontal pathogen load:A preliminary report[J]. Int J Dent, 2021:8925879. DOI: 10.1155/2021/8925879.
|
[48] |
Belkacem Chebil R, Oueslati Y, Marzouk M,et al. Oral lichen planus and lichenoid lesions in sjogren′s syndrome patients:A prospective study[J]. Int J Dent, 2019:1603657. DOI: 10.1155/2019/1603657.
|
[49] |
|
[50] |
Kiyani A, Shahroz N. Synchronous presentation of systemic lupus erythematosus and oral reticular lichen planus[J]. JAAD Case Rep, 2018, 4(2):135-137. DOI: 10.1016/j.jdcr.2017.08.008.
|
[51] |
Agha-Hosseini F,Moosavi MS,Hajifaraj TM. Comparison of oral lichen planus and systemic lupus erythematosus in interleukins level[J]. Arch Iran Med,2015,18(10):703-712.
|
[52] |
Jicha KI, Wang DM, Miedema JR,et al. Cutaneous lupus erythematosus/lichen planus overlap syndrome[J]. JAAD Case Rep, 2021, 17:130-151. DOI: 10.1016/j.jdcr.2021.09.031.
|
[53] |
Duan JY, Duan GC, Wang CJ,et al. Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in a central Chinese urban population:A cross-sectional survey[J]. BMC Nephrol, 2020, 21(1):115. DOI: 10.1186/s12882-020-01761-5.
|
[54] |
Visconti L, Leonardi G, Buemi M,et al. Kidney disease and psoriasis:Novel evidences beyond old concepts[J]. Clin Rheumatol, 2016, 35(2):297-302. DOI: 10.1007/s10067-015-3126-4.
|
[55] |
Lioulios G, Fylaktou A, Papagianni A,et al. T cell markers recount the course of immunosenescence in healthy individuals and chronic kidney disease[J]. Clin Immunol, 2021, 225:108685. DOI: 10.1016/j.clim.2021.108685.
|
[56] |
Oguz U, Takci Z, Oguz ID,et al. Are patients with lichen planus really prone to urolithiasis?Lichen planus and urolithiasis[J]. Int Braz J Urol, 2016, 42(3):571-577. DOI: 10.1590/S1677-5538.IBJU.2015.0364.
|
[57] |
Deng Y, Wang C, Shen Y,et al. Prevalence and risk of chronic kidney disease in oral lichen planus:A large cross-sectional study from eastern China[J]. Ann Transl Med, 2021, 9(13):1078. DOI: 10.21037/atm-21-699.
|
[58] |
Yao H, Deng Y, Du G,et al. Elevated mean platelet volume in oral lichen planus and increased blood urea nitrogen level in its red-form:An observational study[J]. BMC Oral Health, 2021, 21(1):310. DOI: 10.1186/s12903-021-01659-0.
|